Kodiak Sciences Company Insiders
| KOD Stock | USD 6.90 1.32 23.66% |
Kodiak Sciences employs about 113 people. The company is managed by 10 executives with a total tenure of roughly 10 years, averaging almost 1.0 years of service per executive, having 11.3 employees per reported executive. Evaluation of Kodiak Sciences' management performance can provide insight into the firm performance.
| Hong Liang President Senior Vice President - Discovery Medicine |
Kodiak Sciences Management Team Effectiveness
The company has Return on Asset of (0.341) % which means that on every $100 spent on assets, it lost $0.341. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.0892) %, meaning that it generated no profit with money invested by stockholders. Kodiak Sciences' management efficiency ratios could be used to measure how well Kodiak Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Kodiak Sciences Workforce Comparison
Kodiak Sciences is rated fourth overall in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,849. Kodiak Sciences holds roughly 113 in number of employees claiming about 6% of equities under Health Care industry.
Kodiak Sciences Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kodiak Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kodiak Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Kodiak Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kodiak Sciences Notable Stakeholders
A Kodiak Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kodiak Sciences often face trade-offs trying to please all of them. Kodiak Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kodiak Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Hong Liang | Senior Vice President - Discovery Medicine | Profile | |
| Tracy Chien | VP Controller | Profile | |
| Laurent Ducay | Senior Manufacturing | Profile | |
| Almas MSc | Senior Operations | Profile | |
| Victor MD | Chairman, CoFounder | Profile | |
| Michael Louie | Senior Officer | Profile | |
| CPA MBA | CFO VP | Profile | |
| Pablo MD | Senior Development | Profile | |
| Stephen Raillard | Senior Manufacturing | Profile | |
| MD MPH | Chief Officer | Profile |
About Kodiak Sciences Management Performance
The success or failure of an entity such as Kodiak Sciences often depends on how effective the management is. Kodiak Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kodiak management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kodiak management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. Kodiak Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.
Please note, the presentation of Kodiak Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kodiak Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Kodiak Sciences' management manipulating its earnings.
Kodiak Sciences Workforce Analysis
Traditionally, organizations such as Kodiak Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kodiak Sciences within its industry.Kodiak Sciences Manpower Efficiency
Return on Kodiak Sciences Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.6M | |
| Net Loss Per Executive | 17.6M | |
| Working Capital Per Employee | 1.3M | |
| Working Capital Per Executive | 14.6M |
Complementary Tools for Kodiak Stock analysis
When running Kodiak Sciences' price analysis, check to measure Kodiak Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kodiak Sciences is operating at the current time. Most of Kodiak Sciences' value examination focuses on studying past and present price action to predict the probability of Kodiak Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kodiak Sciences' price. Additionally, you may evaluate how the addition of Kodiak Sciences to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |